4,9(11)-pregnadien-17alpha,21-diol-3,20-dione-21-acetate,
anecortave acetate,
Anecortave acetate,
Retaane,
7753-60-8,
UNII-Y0PC411K4T,
AL-3789,
Al 3789,
NSC 15475,
NSC 24345,
Y0PC411K4T,
YUWPMEXLKGOSBF-GACAOOTBSA-N,
21-(Acetyloxy)-17-hydroxypregna-4,9(11)-diene-3,20-dione,
17-Hydroxy-3,20-dioxopregna-4,9(11)-dien-21-yl acetate,
17,21-Dihydroxypregna-4,9(11)-diene-3,20-dione 21-Acetate,
Retaane suspension,
[2-[(8S,10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate,
Anecortave acetate [USAN],
NCGC00181018-01,
Anecortave [INN],
EINECS 231-812-5,
AC1L39DB,
DSSTox_CID_26805,
DSSTox_RID_81919,
DSSTox_GSID_46805,
SCHEMBL94110,
17-Hydroxy-3,20-dioxopregna-4,9(11)-dien-21-yl acetate #,
Anecortave acetate (JAN/USAN),
CHEMBL2106613,
DTXSID5046805,
CHEBI:31215,
CTK6A2433,
NSC15475,
NSC24345,
ZINC3931050,
Tox21_112668,
17-alpha,21-Dihydroxypregna-4,9(11)-diene-3,20-dione 21-acetate,
NSC-15475,
NSC-24345,
AKOS015917580,
ACN-043348,
DB05288,
CAS-7753-60-8,
D01733,
I14-9732,
21-Acetoxypregna-4,9(11)-dien-17|A-ol-3,20-dione,
21-acetoxy-17-hydroxy-4,9(11)-pregnadiene-3,20-dione,
17alpha-hydroxy-21-acetoxypregna-4,9(11)-diene-3,20-dione,
Pregn-4,9(11)-dien-17,21-diol-3,20-dione, acetate(ester),
17alpha-hydroxy-21 -acetoxy-pregna-4,9(11)-diene-3,20-dione,
Pregna-4,9(11)-diene-3,20-dione, 21-(acetyloxy)-17-hydroxy-,
Pregna-4,9(11)-diene-3,20-dione,21-(acetyloxy)-17-hydroxy-,
2-((8S,10S,13S,14S,17R)-17-Hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate,
Anecortave,
Retaane (TN),
D02CNR,
C23H30O5,
CID111332,
C23-H30-O5,
ANECORTAVE ACETATE (200 MG)F0E2980.997MG/MG(AI),
delta-4,9(11)-pregnadien-17-alpha,21-diol-3,20-dione-21-acetate,